blank.
Account Cart (0)

New Batch COAs ♦ Free Shipping $200+

blank.
(0)
Blank Peptides — Wholesale Division

Wholesale Program
Terms & Conditions

Professional Use & Research Use Agreement

These terms establish the legally binding framework governing the purchase, handling, and professional application of research-grade peptide materials supplied by Blank Peptides. By placing an order or maintaining an active wholesale account, the Authorized Purchaser agrees to all terms herein.

Effective Date: April 12, 2026 • Version 2.0

Important: All products sold by Blank Peptides are designated for Research Use Only (RUO) and/or Professional Use Only (PUO). Products are not FDA-approved drugs. They are not intended for human consumption outside of supervised professional clinical protocols with appropriate informed consent. By proceeding, you acknowledge and accept the regulatory framework described herein.

Section 01

Definitions

Material / Product
Any peptide compound, lyophilized preparation, reconstituted solution, or ancillary supply provided by Blank Peptides (“Supplier”) under this wholesale agreement.
Authorized Purchaser
Any verified entity or individual that has completed the application and credentialing process and maintains an active wholesale account in good standing.
RUO — Research Use Only
Designation indicating materials are intended exclusively for in-vitro diagnostic, investigational, and laboratory research purposes. RUO materials have not been FDA-approved for diagnostic or therapeutic use.
PUO — Professional Use Only
Designation indicating materials may be utilized within supervised professional clinical protocols by licensed practitioners who accept full clinical responsibility, maintain proper informed consent documentation, and operate within the scope of their professional license and applicable state regulations.
COA — Certificate of Analysis
Batch-specific documentation verifying purity, identity, and potency through independent third-party HPLC and mass spectrometry testing. Provided with every shipment.
NPI
National Provider Identifier — a unique 10-digit identification number issued by CMS to healthcare providers in the United States. Required for practitioner account verification.
Section 02

Product Classification & Regulatory Status

Blank Peptides is not a compounding pharmacy under Section 503A of the Federal Food, Drug, and Cosmetic Act, nor an outsourcing facility under Section 503B. Products are manufactured in a US-based facility following current Good Manufacturing Practice (cGMP) protocols.

All materials are designated Research Use Only (RUO) and are sold as research chemicals. Products have not been evaluated or approved by the U.S. Food and Drug Administration (FDA) and are not intended to diagnose, treat, cure, or prevent any disease.

Licensed practitioners who utilize materials within professional clinical protocols do so under their own medical authority, license, and professional liability insurance. This is referred to as Professional Use Only (PUO) and requires adherence to the practitioner obligations set forth in Section 04 of these terms.

Every batch undergoes independent third-party HPLC and mass spectrometry testing before release. Certificates of Analysis accompany all shipments. If a batch does not meet our purity or quality standards, it is rejected — borderline products are never released.

Section 03

Eligibility & Account Verification

Wholesale accounts are limited to verified professionals and institutions. Applicants must provide at least one of the following:

  • Licensed medical practitioners with an active NPI number and valid state medical license (MD, DO, NP, PA, or equivalent)
  • Medical spas and clinics operating under the supervision of a licensed medical director with an active NPI
  • Wellness centers and integrative practices with licensed practitioner oversight and appropriate facility documentation
  • Research institutions and laboratories with institutional accreditation (CLIA, IRB approval, or equivalent)
  • Pharmaceutical distributors with valid DEA registration and state-level distribution licenses

Blank Peptides reserves the right to verify credentials at any time, request additional documentation, and deny or revoke access at its sole discretion. Providing false or misleading credentials constitutes fraud and will result in immediate account termination and potential legal referral.

Section 04

Practitioner Obligations & Professional Use

Practitioners utilizing materials within professional clinical protocols (PUO designation) accept and acknowledge the following obligations:

  • I am a licensed healthcare professional authorized to prescribe, administer, or supervise the administration of injectable compounds within my jurisdiction.
  • I will maintain comprehensive informed consent documentation for every patient receiving peptide-based protocols, including: (a) the nature of the compound and that it is not FDA-approved for therapeutic use; (b) the rationale for recommending the therapy; (c) expected benefits and potential risks; (d) alternative treatment options; (e) the patient’s right to decline or discontinue at any time.
  • I accept full clinical responsibility for patient assessment, dosing decisions, administration protocols, adverse event monitoring, and all outcomes related to professional use of these materials.
  • I will maintain professional liability (malpractice) insurance adequate to cover any claims arising from my use of these products in clinical practice.
  • I will not represent these materials as FDA-approved drugs or make therapeutic claims not supported by peer-reviewed evidence.
  • I will maintain accurate treatment records and adverse event documentation in accordance with applicable medical record-keeping laws.
  • I understand that Blank Peptides provides research-grade materials and assumes no clinical liability for practitioner decisions regarding patient care.
  • I will comply with all applicable federal, state, and local laws, regulations, and professional board requirements governing my use of these materials.
Section 05

Intended Use & Restrictions

Purchaser acknowledges and agrees to the following use restrictions:

  • Products are designated Research Use Only (RUO). Use within professional clinical protocols (PUO) is permitted only by licensed practitioners who comply with the obligations in Section 04.
  • Products must NOT be marketed, labeled, promoted, or sold as drugs, dietary supplements, cosmetics, or consumer products under any circumstances.
  • Products must NOT be resold on Amazon, eBay, Etsy, Facebook Marketplace, TikTok Shop, or any other consumer-facing marketplace.
  • Products must NOT be distributed to unlicensed individuals or entities without prior written authorization from Blank Peptides.
  • All documentation, invoices, labels, and communications related to these products must prominently display the “Research Use Only” designation.
  • Purchaser will not make any claim or representation that products are manufactured by, endorsed by, or affiliated with any pharmaceutical company or FDA-regulated entity.
  • Purchaser assumes sole responsibility for compliance with all applicable federal, state, and local laws governing research materials, controlled substances, and professional clinical practice.
Section 06

Quality Assurance & Manufacturing Standards

Blank Peptides is committed to pharmaceutical-grade quality at every stage of production:

  • cGMP manufacturing protocols — the same framework required for FDA-approved pharmaceutical production, exceeding the USP <795>/<797> compounding guidelines used by 503A pharmacies
  • Third-party analytical testing — every batch undergoes independent HPLC (High Performance Liquid Chromatography) and mass spectrometry analysis at accredited laboratories before release
  • Purity standards — minimum ≥99% purity verified on all peptide products, with batch-specific Certificates of Analysis provided with each shipment
  • Identity confirmation — molecular weight and amino acid sequence verification via mass spectrometry to ensure exact compound identity
  • Endotoxin and sterility testing — conducted on all injectable-format products to verify safety for professional use applications
  • Full traceability — lot tracking from raw material sourcing through synthesis, purification, lyophilization, testing, and final release

COA documentation is available upon request and is also accessible through your wholesale account portal. Any batch that fails to meet specifications is rejected and destroyed — we do not release borderline products.

Section 07

Account Tiers & Pricing

Tier 1 — Starter
$1,000 – $5,000 Monthly Volume
5% Volume Discount
Tier 2 — Professional
$5,000 – $25,000 Monthly Volume
12% Volume Discount
Tier 3 — Enterprise
$25,000+ Monthly Volume
Custom Pricing • Dedicated Account Manager

Volume discounts are calculated on 90-day rolling averages. Tier placement is reviewed quarterly. Blank Peptides reserves the right to modify tier thresholds and discount structures with 30 days written notice.

Section 08

Ordering & Payment

All wholesale orders are placed through your dedicated account representative after your application has been approved and credentials verified. Payment terms, volume pricing, and billing arrangements are established during the onboarding process and tailored to your practice’s needs.

To begin the application process or inquire about wholesale pricing, submit a request through our Wholesale Application or contact us directly at [email protected].

Late payments may result in account suspension. Blank Peptides reserves the right to modify payment terms at any time with written notice. All prices are in USD. Applicable sales tax will be added where required by law.

Section 09

Shipping, Handling & Storage

Fulfillment
Orders ship same-day if placed before 12:00 PM CST. High-volume orders (100+ units) may require 3–5 business days for custom labeling and quality verification.
Packaging
All products ship in lyophilized (freeze-dried) form—a format inherently resistant to temperature variation during transit. Cold-chain logistics are not required; lyophilized material retains full structural integrity under standard shipping conditions. Each shipment includes tamper-evident seals and batch ID tracking.
Inspection
48-hour inspection window upon delivery. Report any damage, discrepancies, or compromised packaging immediately. We stand behind our products and will replace affected orders.
Storage
Lyophilized (unreconstituted): Refrigerate at 2–8°C (36–46°F) for near-term use; freeze at −20°C or colder for extended storage. Stable at controlled room temperature (≤25°C / 77°F) for 6–12 months; frozen storage extends viability to 5+ years. After reconstitution: Keep refrigerated at 2–6°C (36–43°F) and use within the product-specific window (generally 14–28 days). Precautions: Shield from direct light, avoid sustained heat exposure, and minimize freeze-thaw cycling. Always follow any product-specific insert.

All products leave our facility in lyophilized (freeze-dried) form—a format inherently resistant to temperature variation during transit. Cold-chain logistics are not required; lyophilized material retains full structural integrity under standard shipping conditions. The practitioner reconstitutes the peptide on-site before use. Risk of loss transfers to the Purchaser upon carrier delivery confirmation.

Section 10

Marketing & Resale Restrictions

Purchaser agrees to the following marketing and distribution restrictions:

  • Products may NOT be resold on any consumer-facing marketplace including but not limited to: Amazon, eBay, Etsy, Facebook Marketplace, TikTok Shop, Walmart.com, or any similar platform.
  • Products may NOT be advertised using therapeutic or medical claims, including claims of disease treatment, cure, or prevention.
  • All product references in purchaser materials, websites, invoices, and communications must include the “Research Use Only” or “Professional Use Only” designation.
  • Use of Blank Peptides brand assets (logos, trade names, product images) requires prior written approval.
  • Third-party distribution or sub-wholesale of products is strictly prohibited without an executed distribution agreement from Blank Peptides.
  • Purchaser must not engage in any advertising, social media activity, or public communication that could bring Blank Peptides into disrepute or regulatory scrutiny.

Violation of any marketing or resale restriction results in immediate and permanent account termination, forfeiture of pending orders, and pursuit of all legal remedies available.

Section 11

Warranties & Disclaimers

Limited warranty: Blank Peptides warrants that all materials conform to the specifications stated on the accompanying Certificate of Analysis at the time of shipment. This is the sole and exclusive warranty provided.

Disclaimer: EXCEPT AS EXPRESSLY SET FORTH ABOVE, ALL MATERIALS ARE PROVIDED “AS IS” WITHOUT WARRANTY OF ANY KIND, EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NON-INFRINGEMENT.

Blank Peptides makes no warranty or representation regarding the suitability of materials for any specific research application, clinical protocol, or therapeutic use. Purchaser is solely responsible for determining appropriate use within their professional scope.

Blank Peptides does not warrant uninterrupted product availability and reserves the right to discontinue any product line with reasonable notice.

Section 12

Limitation of Liability & Indemnification

Limitation of liability: IN NO EVENT SHALL BLANK PEPTIDES, ITS OFFICERS, DIRECTORS, EMPLOYEES, OR AGENTS BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR PUNITIVE DAMAGES ARISING FROM OR RELATED TO THE SALE, USE, OR INABILITY TO USE MATERIALS, REGARDLESS OF THE THEORY OF LIABILITY.

Blank Peptides’ total aggregate liability under this agreement shall not exceed the purchase price paid by Purchaser for the specific product(s) giving rise to the claim.

Indemnification: Purchaser agrees to indemnify, defend, and hold harmless Blank Peptides, its officers, directors, employees, agents, and affiliates from and against any and all claims, liabilities, damages, losses, costs, and expenses (including reasonable attorneys’ fees) arising from or related to:

  • Purchaser’s use, storage, handling, administration, or distribution of materials
  • Any clinical outcomes, adverse events, or patient claims related to Purchaser’s professional use of materials
  • Purchaser’s breach of any term or condition of this agreement
  • Purchaser’s violation of any applicable law, regulation, or professional licensing requirement
  • Any misrepresentation by Purchaser regarding the regulatory status, source, or intended use of materials
Section 13

Compliance, Auditing & Record Keeping

Purchaser agrees to maintain complete and accurate records of all product purchases, inventory, usage, and distribution for a minimum period of five (5) years from the date of purchase.

Blank Peptides reserves the right to audit purchaser records and, where applicable, facility operations to verify compliance with these wholesale terms. Audits may be conducted:

  • With 14 calendar days written notice for routine compliance verification
  • Without prior notice in cases of suspected violation, fraud, or regulatory inquiry
  • By Blank Peptides directly or through authorized third-party compliance auditors

Accounts may be suspended immediately and terminated permanently for: non-compliance with terms, unauthorized resale, misrepresentation of credentials, failure to maintain required documentation, or violation of RUO/PUO use restrictions.

In the event of a regulatory inquiry by any government agency concerning products purchased from Blank Peptides, Purchaser shall promptly notify Blank Peptides and cooperate fully in any investigation.

Section 14

Governing Law & Dispute Resolution

This agreement shall be governed by and construed in accordance with the laws of the State of Texas, without regard to its conflict of law principles.

Any dispute arising from or relating to this agreement shall first be submitted to good-faith mediation. If mediation is unsuccessful within 30 days, disputes shall be resolved by binding arbitration administered by the American Arbitration Association (AAA) under its Commercial Arbitration Rules. The arbitration shall take place in Texas.

Notwithstanding the foregoing, Blank Peptides may seek injunctive or equitable relief in any court of competent jurisdiction to enforce intellectual property rights, prevent unauthorized resale, or address violations requiring immediate remedy.

Severability: If any provision of this agreement is found to be unenforceable, the remaining provisions shall continue in full force and effect.

Modifications: Blank Peptides reserves the right to modify these terms at any time. Material changes will be communicated via email to account holders at least 30 days in advance. Continued use of the wholesale account following notice of changes constitutes acceptance of modified terms.

Entire agreement: These terms, together with any executed wholesale account application, constitute the entire agreement between the parties and supersede all prior negotiations, representations, or agreements relating to the subject matter herein.

Frequently Asked Questions
Research Use Only (RUO) indicates a product has been manufactured and tested for laboratory, investigational, or research applications—it has not undergone the FDA approval process for therapeutic or diagnostic use. Professional Use Only (PUO) describes the practice of incorporating RUO-grade materials into supervised clinical settings under the authority of a licensed healthcare provider who assumes full clinical accountability and secures documented informed consent from each patient. All Blank Peptides products carry the RUO designation; practitioners who integrate them into patient care do so under the PUO framework at their own professional judgment and liability.
Factor503A Compounding PharmacyBlank Peptides
RegulationGoverned by state pharmacy boardsManufactured under cGMP pharmaceutical protocols
Rx RequirementPatient-specific prescription requiredNo Rx needed — physician-directed professional use
Intended UseCompounded for a single named patientBatch-produced for verified professional accounts
Analytical TestingInconsistent; depends on the pharmacyEvery lot independently tested (HPLC & mass spec COA)
Catalog BreadthConstrained by evolving FDA category rulesWider range of peptide compounds & concentrations
CostElevated (dispensing fees + pharmacy margin)Manufacturer-direct wholesale pricing
Lead TimeVaries with individual pharmacy workloadStocked inventory; ships same day
Applicants must submit at least one qualifying credential: a current NPI (National Provider Identifier), an active state medical license (MD, DO, NP, PA, or equivalent), CLIA certification for lab settings, or recognized institutional research accreditation. Medical spas and wellness clinics should include their supervising medical director’s license documentation. Every credential must be current and in good standing—NPI numbers are cross-referenced with the CMS NPPES database during review.
Licensed practitioners across the country incorporate professional-use peptides into their clinical workflows with proper documentation and consent. The essential requirements: informed consent disclosing that the product has not received FDA therapeutic approval, your clinical rationale for the protocol, anticipated benefits alongside potential risks, available alternatives, and the patient’s unconditional right to refuse or discontinue. You must also carry adequate malpractice coverage and practice within the boundaries of your licensure. Full details are outlined in Section 04 of these terms.
Practitioners consistently report that patients respond positively when given a straightforward explanation of the regulatory landscape. Key points that resonate: the manufacturing rigor behind each product (cGMP production, independent analytical testing), the reason many effective peptides haven’t gone through the traditional approval pathway (naturally occurring compounds generally cannot be patented, which removes the economic motivation for multi-million-dollar FDA trials), the clinician’s own experience and evidence-based rationale, and the mutual protection that thorough informed consent provides. Transparency builds trust—and patients tend to appreciate practices that lead with it.
No. A compounding pharmacy’s warranty typically extends only to the accuracy of the fill—they prepared the compound as prescribed. Every clinical decision—patient selection, dosing protocol, ongoing monitoring, and adverse-event management—remains the responsibility of the prescriber regardless of where the product originates. The more meaningful question is documentation strength: our cGMP-manufactured products are accompanied by independent third-party COAs that substantiate purity and identity, giving you a robust evidentiary foundation that may exceed what some compounding pharmacies can provide.
Products are intended for use within your own professional setting. Listing on consumer marketplaces (Amazon, eBay, Etsy, Facebook, TikTok Shop, etc.) or direct-to-consumer retail is expressly prohibited. Administration within clinical protocols at your licensed facility is fully permitted. Redistribution or sub-wholesale arrangements with other practices require a separate written agreement executed by Blank Peptides. Any breach of these resale restrictions triggers immediate and permanent termination of your wholesale account.
Minimum order requirements and pricing tiers are discussed during the account setup process. Your dedicated account representative will provide a custom pricing sheet based on your anticipated volume, product mix, and ordering frequency. Contact us at [email protected] to begin the application process.
Each Certificate of Analysis includes batch-specific information including lot number, synthesis date, purity results, and the independent testing laboratory’s name and accreditation. COAs can be verified by contacting our wholesale team or through your account portal. We are happy to provide additional documentation, connect you directly with our testing laboratory, or arrange for independent verification if needed.
Contact us immediately within the 48-hour inspection window. We stand behind our products and will replace any order that arrives with damage or compromised packaging at no additional cost. Document the condition with photographs to expedite resolution. Our goal is to make every situation right — we view quality issues as data that helps us continually improve our packaging and fulfillment processes.
Bringing a compound through the full FDA approval pipeline typically requires upwards of $100 million and a decade or more of clinical trials. That level of investment is only viable when strong patent rights allow the sponsor to recover costs over an exclusivity window. Because many peptides are endogenous or naturally derived, they fall outside conventional patent protection—which eliminates the commercial incentive for formal trials, irrespective of real-world safety or efficacy data. Put simply, the absence of FDA approval reflects economics, not risk. The approval process confirms that a drug treats a specific indication; it does not, on its own, guarantee manufacturing quality. Our cGMP production and independent analytical testing address the quality question directly.
Broader access — Source peptide compounds that are no longer available through the compounding pathway due to evolving FDA category decisions. Lower cost — Eliminate pharmacy dispensing fees and middleman markups with direct manufacturer pricing. Uniform quality — Every lot is produced under cGMP conditions and verified by independent analytical testing before release. Reliable supply — Stocked inventory ships promptly, free from the backlog constraints that affect individual pharmacies. Wider catalog — A more comprehensive selection of peptide compounds and dosage formats. The trade-off is administrative: 503A compounding sits within well-established pharmacy regulation and recognized oversight structures, while professional-use sourcing asks the practitioner to build their own compliant protocols and informed consent framework. For many clinicians, the advantages in access, economics, and consistency make that investment well worth the effort.
It’s a reasonable assumption—and one worth unpacking. 503A pharmacies operate under state pharmacy board oversight, not direct FDA regulation, and both inspection frequency and enforcement rigor differ significantly from state to state. Their production follows USP compounding standards (<795>/<797>), which were designed for small-scale preparation and are distinct from—and generally less demanding than—the cGMP framework used in pharmaceutical manufacturing. Crucially, quality testing practices are pharmacy-specific and can range widely. Our facility operates under cGMP protocols, and every production lot is independently verified before release. Rather than framing the decision as “pharmacy versus professional use,” the better question is: what specific quality controls are in place, and can the supplier document them? We can—on every batch.
Compounding pharmacies operate under USP <795> and <797> standards, which were written for pharmacy-level preparation. Our production adheres to cGMP—the same manufacturing framework that governs FDA-approved pharmaceutical facilities. Each lot undergoes independent HPLC purity analysis and mass spectrometry identity confirmation before it is cleared for distribution. A useful exercise: ask your current compounder what analytical testing they perform per batch and whether they can furnish an independent, lab-verified Certificate of Analysis for each lot they dispense.
Because we sell direct from the manufacturer, our wholesale pricing eliminates the dispensing fees and pharmacy margins that inflate 503A costs. The result is a materially lower per-unit price point that strengthens practice economics and can expand patient access to peptide protocols. Exact pricing is tailored to your account during onboarding—request wholesale access to receive a custom quote based on your anticipated volume and product mix.
Peptides are short amino acid sequences—many identical or closely related to molecules your body already synthesizes. As a class, they share several favorable characteristics: rapid half-lives (the body metabolizes them quickly, avoiding tissue buildup), predictable breakdown pathways (degraded into standard amino acids that are utilized or excreted normally), and highly specific mechanisms of action. Where adverse events do appear in published literature, they are overwhelmingly linked to dosing errors or inadequate patient education rather than inherent product concerns. This underscores why Blank Peptides prioritizes robust informed consent frameworks and practitioner-level guidance for every protocol.
Absolutely. A growing number of clinicians—spanning integrative and functional medicine, regenerative health, longevity-focused practices, and sports medicine—routinely use peptide protocols with their patients under structured, consent-driven frameworks. Our wholesale network includes well-established practices that have built compliant internal workflows complete with physician oversight, standardized documentation, and ongoing patient monitoring.
Lyophilized (unreconstituted): Keep refrigerated at 2–8°C (36–46°F) for near-term use, or store frozen at −20°C (−4°F) or colder for extended shelf life. At controlled room temperature (below 25°C / 77°F), lyophilized peptides remain stable for approximately 6–12 months; frozen storage extends viability to five years or longer. Once reconstituted: Refrigerate between 2–6°C (36–43°F) and administer within the product-specific window—generally 14–28 days. General precautions: Shield from direct light, avoid prolonged heat exposure, and minimize freeze-thaw cycling. Always defer to the product-specific insert when available.
All peptides leave our facility in lyophilized (freeze-dried) form—a format that is inherently resistant to temperature fluctuations during transit. Cold-chain logistics are not required for lyophilized material; the product maintains full structural integrity under standard ground and air shipping conditions. The practitioner or end user reconstitutes the peptide on-site prior to use.
The majority of applications clear review within one business day. Our verification process cross-checks your NPI against the CMS NPPES database, confirms active state licensure, and evaluates any supporting facility documentation you provide. Upon approval you receive wholesale account credentials, a personalized pricing schedule, and immediate ordering access. Applications from multi-site practices or research institutions may involve supplemental documentation and typically finalize within 3–5 business days.
Given the nature of research-grade materials and storage-sensitive logistics, sales are considered final once the shipment has left our facility. That said, we fully stand behind product quality: any order that arrives with visible damage, compromised seals, or test results that fall outside COA specifications will be replaced at our expense. If you suspect a lot does not conform to its published purity or identity data, reach out with the lot number—we will initiate an investigation promptly, including commissioning independent re-analysis when warranted. Quality concerns are treated as priority action items, not complaints.

Ready to Partner with Blank Peptides?

Apply for Wholesale Access

Credential review typically completes within 1 business day.
Questions? Contact us at [email protected]